Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

ClinicalTrials.gov ID: NCT00941798

Public ClinicalTrials.gov record NCT00941798. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 11:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multi-center, Parallel Group, Double Blind, Study to Assess the Safety of QMF Twisthaler® (500/400 µg) and Mometasone Furoate Twisthaler® (400 µg) in Adolescent and Adult Patients With Persistent Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study CQMF149A2210 evaluated the safety of QMF149 Twisthaler® 500/400 μg, a fixed dose combination of indacaterol 500 μg, a once daily β2 agonist, and mometasone furoate 400 μg, an inhaled corticosteroid (ICS) that is approved for use in the treatment of asthma. The objective of this safety trial was to assess the effect of treatment on the incidence of serious asthma exacerbations, defined as asthma related hospitalization and/or intubation and/or death. This was an event driven trial.

Study identification

NCT ID
NCT00941798
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
2,283 participants

Conditions and interventions

Conditions

Eligibility (public fields only)

Age range
12 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2009
Primary completion
Apr 30, 2011
Completion
Apr 30, 2011
Last update posted
Aug 30, 2012

2009 – 2011

United States locations

U.S. sites
92
U.S. states
34
U.S. cities
83
Facility City State ZIP Site status
Novartis Investigator Site Birmingham Alabama 35209
Novartis Investigator Site Buena Park California 90620
Novartis Investigator Site Encinitas California 92024
Novartis Investigator Site Fullerton California 92835
Novartis Investigator Site Long Beach California 90808
Novartis Investigator Site Los Angeles California 90025
Novartis Investigator Site Orange California 92868
Novartis Investigator Site Riverside California 92506
Novartis Investigator Site San Diego California 92123
Novartis Investigator Site San Jose California 95117
Novartis Investigator Site San Mateo California 94401
Novartis Investigator Site Vista California 92083
Novartis Investigator Site Walnut Creek California 94598
Novartis Investigator Site Denver Colorado 80230
Novartis Investigator Site Engelwood Colorado 80112
Novartis Investigator Site Lakewood Colorado 80401
Novartis Investigator Site Wheat Ridge Colorado 80033
Novartis Investigator Site Clearwater Florida 33756
Novartis Investigator Site Clearwater Florida 33765
Novartis Investigative Site Miami Florida 33136
Novartis Investigative Site Miami Florida 33157
Novartis Investigator Site Port Charlotte Florida 33952
Novartis Investigator Site Sarasota Florida 34233
Novartis Investigative Site South Miami Florida 33143
Novartis Investigator Site Tampa Florida 33603
Novartis Investigative Site Albany Georgia 31707
Novartis Investigative Site Columbus Georgia 31904
Novartis Investigative Site Savannah Georgia 31406
Novartis Investigator Site Couer D'Alene Idaho 83814
Novartis Investigator Site Chicago Illinois 60612
Novartis Investigator Site Normal Illinois 61761
Novartis Investigator Site River Forest Illinois 60305
Novartis Investigator Site Skokie Illinois 60076
Novartis Investigator Site Springfield Illinois 62703
Novartis Investigator Site Evansville Indiana 47713
Novartis Investigator Site Indianapolis Indiana 46208
Novartis Investigator Site Iowa City Iowa 52240
Novartis Investigator Site Topeka Kansas 66606
Novartis Investigator Site Owensboro Kentucky 42301
Novartis Investigator Site Metarie Louisiana 70002
Novartis Investigative Site Bangor Maine 04401
Novartis Investigative Site Baltimore Maryland 21236
Novartis Investigative Site Baltimore Maryland 21237
Novartis Investigative Site North Dartmouth Massachusetts 02747
Novartis Investigator Site Minneapolis Minnesota 55402
Novartis Investigator Site Plymouth Minnesota 55441
Novartis Investigator Site Ozark Missouri 65721
Novartis Investigator Site Rolla Missouri 65401
Novartis Investigator Site St Louis Missouri 63141
Novartis Investigator Site Warrensburg Missouri 64093
Novartis Investigator Site Bellevue Nebraska 68123
Novartis Investigator Site Omaha Nebraska 68130
Novartis Investigator Site Omaha Nebraska 68131
Novartis Investigative Site Brick New Jersey 08724
Novartis Investigative Site Cedar Knolls New Jersey 07927
Novartis Investigative Site Skillman New Jersey 08558
Novartis Investigator Site Albuquerque New Mexico 87108
Novartis Investigative Site Mineola New York 11501
Novartis Investigative Site Newburgh New York 12550
Novartis Investigative Site Rochester New York 14618-2638
Novartis Investigative Site High Point North Carolina 27262
Novartis Investigative site Raleigh North Carolina 27607
Novartis Investigator Site Canton Ohio 44718
Novartis Investigator Site Columbus Ohio 43213
Novartis Investigator Site Marion Ohio 43302
Novartis Investigator Site Sylvania Ohio 43560
Novartis Investigative Site Oklahoma City Oklahoma 73104
Novartis Investigator Site Oklahoma City Oklahoma 73112
Novartis Investigator Site Oklahoma City Oklahoma 73120
Novartis Investigator Site Portland Oregon 97213
Novartis Investigative Site Blue Bell Pennsylvania 19422
Novartis Investigative Site Philadelphia Pennsylvania 19115
Novartis Investigative site Philadelphia Pennsylvania 19140
Novartis Investigative Site Pittsburgh Pennsylvania 15221
Novartis Investigator Site Lincoln Rhode Island 02865
Novartis Investigative Site Mt. Pleasant South Carolina 29464
Novartis Investigator Site Kingsport Tennessee 37660
Novartis Investigator Site Dallas Texas 75230
Novartis Investigator Site Dallas Texas 75231
Novartis Investigator Site Dickinson Texas 77539
Novartis Investigator Site El Paso Texas 79925
Novartis Investigator Site Fort Worth Texas 76132
Novartis Investigative Site Houston Texas 77030
Novartis Investigator Site Houston Texas 77054
Novartis Investigator Site New Braunfels Texas 78130
Novartis Investigator Site San Antonio Texas 78229
Novartis Investigative Site South Burlington Vermont 05403
Novartis Investigative Site Abingdon Virginia 24210
Novartis Investigator Site Kirkland Washington 98034
Novartis Investigator Site Seattle Washington 98105
Novartis Investigator Site Tacoma Washington 98405
Novartis Investigator Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00941798, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 30, 2012 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00941798 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →